Introduction
Tigecycline is the prototype of the recently introduced, intravenously administered glycylcycline class of antibiotics, developed in response to the increasing problem of antibiotic resistance in Gram-positive bacteria, especially Staphylococcus aureus, as well as Gram-negative bacteria and anaerobes. [1] [2] [3] Tigecycline is similar to tetracyclines with respect to both molecular structure and mechanism of antimicrobial action, but possesses a broader spectrum of activity due to a minor structural modification, specifically a glycylcycline substitution at the C-9 position of the naphthalene ring. [1] [2] [3] Although it is concentrated by human neutrophils in vitro, 4 little is known about the effects of tigecycline on the pro-inflammatory/anti-inflammatory activities of these cells. Given their critical involvement in the eradication of extracellular pathogens, especially Staphylococcus aureus, 5, 6 cooperative interactions between neutrophils and tigecycline are likely to be a determinant of the successful outcome of antimicrobial chemotherapy. 7 Alternatively, enhancement of the pro-inflammatory activities of these cells may exacerbate inflammation-mediated tissue damage and organ dysfunction through increased release of indiscriminate reactive oxygen species (ROS) and granule proteases. 7 In the current study, we have investigated the effects of tigecycline on alterations in cytosolic Ca 2+ concentrations, generation of antimicrobial ROS and release of granule proteases, following activation of neutrophils with the chemoattractant, fMLP. The generation of ROS was determined according to the magnitude of oxygen consumption by activated neutrophils, a measure of activity of the membrane-associated, electron-transporting, superoxidegenerating enzyme-complex, NADPH oxidase. This was complemented by measurement of the activity of the myeloperoxidase (MPO) / hydrogen peroxide (H 2 O 2 ) / halide system. This is a composite assay of the production of superoxide and H 2 O 2 , as well as the release of MPO from primary granules.
MPO and H 2 O 2 interact to form hypochlorous acid, an extremely potent antimicrobial ROS. Measurement of the primary granule protease, elastase, and the secondary / tertiary granule proteases, matrix metalloproteinases (MMPs)-8 and -9, was included because of their involvement in promoting neutrophil migration and killing of microbial pathogens, while increases in cytosolic Ca 2+ precede and are a prerequisite for activation of both generation of ROS and release of granule enzymes. 7 The underlying hypothesis is that tigecycline modulates the pro- Africa). In most of the assays described below tigecycline was used at final concentrations of 0.625 -10 mg/L, the exception being in assays of influx of extracellular Ca 2+ at which concentrations of up to 40 mg/L were used.
Following intravenous infusion of 100 mg tigecycline, peak serum levels of up to 27 mg/L have been documented immediately following infusion, with a mean value of 1.94 mg/L, 9 while a mean value of about 6 mg/L has been reported following a single infusion of 400 mg of the antibiotic to patients with multidrug-resistant Klebsiella pneumoniae or Acinetobacter baumannii urosepsis. 10 Leucocyte and tissue (colon, gallbladder, lung) concentrations are considerably higher than those of serum. 4, [9] [10] [11] Unless indicated, all other chemicals and reagents were purchased from the Sigma Chemical Co.
Neutrophils
Permission to draw blood from healthy, adult human volunteers was granted by 
Neutrophil function assays
Where possible, assays were selected which were not prone to interference by the yellow colour of tigecycline.
Myeloperoxidase (MPO)-mediated iodination
Neutrophils (1x10 In an additional series of experiments, the effects of doxcycline, minocycline, and tetracycline at concentrations of 5 and 10 mg/L on fMLP/CB-activated neutrophil auto-iodination were investigated.
Oxidant scavenging by tigecycline
A cell-free ROS-generating system based on MPO-mediated iodination of bovine serum albumin (BSA) was used to measure the ROS-scavenging potential of tigecycline. Briefly, reaction systems contained purified MPO (100 milliunits/mL) isolated from human neutrophils, glucose oxidase (1.55 units/mL, from bovine liver), HBSS containing 5 mM glucose, 20 nmol/mL cold carrier NaI, 2 µCi 
Oxygen consumption
This was measured using a thermo-regulated 3-channel oxygen electrode 
Release of granule proteases
The granule proteases elastase (primary granules) and matrix metalloproteinases-8 and -9 (MMP-8 and -9, secondary and secondary/tertiary granules respectively) were measured following activation 
Radiometric assessment of Ca 2+ influx
This procedure was used to measure the net influx of 45 ) in a final volume of 5 mL were then incubated for 5 min at 37°C after which chemoattractant-activated, store-operated uptake of Ca 2+ is complete, 13 -replete HBSS were then pre-incubated for 10 min without and with tigecycline followed by addition of fMLP (1 µM) or an equal volume of HBSS to unstimulated systems and incubated for 1 min at 37°C after which efflux is complete. 13 Reactions were terminated and the cells processed as above and the amount of residual cell-associated 45 
Ca

2+
determined.
In an additional series of experiments, the effects of the following on the spontaneous uptake of 45 Ca 2+ (ie in the absence of fMLP) were also 
Results
MPO-mediated iodination
The effects of tigecycline on MPO-mediated neutrophil auto-iodination are shown in Figure 1A . 
Granule proteases
The effects of tigecycline on the release of the granule proteases elastase, MMP-8, and MMP-9 are shown in , which levelled off at about 2 min after the addition of fMLP coincident with store-operated Ca 2+ influx. 13 In the presence of tigecycline, the rate of decline in fluorescence intensity was slower, compatible with higher post-peak cytosolic Ca hypohalous acid-scavenging properties of tigecycline as described in the current study, as well as in previous studies for other members of the tetracycline group of antibiotics, [14] [15] [16] demonstrating that these agents possess both pro-oxidative and anti-oxidative properties.
In the therapeutic setting, the pro-oxidative interactions of tigecycline with neutrophils, if predominant, may be either beneficial or harmful. In the case of the former, the increased generation of microbicidal ROS by tigecycline-treated neutrophils is likely to contribute to host defence against bacterial pathogens, already weakened by the direct antibiotic action of tigecycline.
17,18
On the other hand, however, increased production of indiscriminate ROS poses the potential hazard of oxidant-mediated damage to bystander host cells and tissues. However, tetracyclines also possess well-recognised proinflammatory/irritant properties, due at least in part to Ca 2+ ionophore activity. 
